CMV UL56 terminase — Drug Target

All drugs that target CMV UL56 terminase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

CMV terminase inhibitor

Phase 3 pipeline (1)

• Letermovir IV · Merck Sharp & Dohme LLC · CMV terminase inhibitor · Infectious Disease / Virology
  Letermovir inhibits the viral terminase enzyme of cytomegalovirus (CMV), preventing viral DNA packaging and replication.